APO Research
Talk to an analyst

APO RESEARCH · REPORT

Liganlong Granules

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Liganlong Granules Market Outlook and Growth Opportunities 2026

29 December 2025213 pages

Choose your research edition.

Industry ResearchLiganlong Granules Industry Research Report 2026151 pages · $2,950 USDIndustry Growth & TrendsGlobal Liganlong Granules Industry Growth and Trends Forecast to 2032123 pages · $3,450 USDMarket StructureGlobal Liganlong Granules Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Liganlong Granules Market Outlook and Growth Opportunities 2026213 pages · $4,250 USDMarket Analysis & ForecastGlobal Liganlong Granules Market Analysis and Forecast 2026-2032210 pages · $4,950 USD

Market perspective

The global Liganlong Granules market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Liganlong Granules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Liganlong Granules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Liganlong Granules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Liganlong Granules market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Liganlong Granules market include Zhongjing Wanxi Pharmaceutical Co., Ltd., Tibet Tibetan Medicine Group Co., Ltd., Sichuan Luye Pharmaceutical Co., Ltd., Liaoning Wohua Kangchen Pharmaceutical Co., Ltd., Liaoning Keji Pharmaceutical Co., Ltd., Liaoning Dongyi Pharmaceutical Co., Ltd., Jiangxi Chuanqi Pharmaceutical Co., Ltd., Jilin Yatai Pharmaceutical Co., Ltd. and Jilin Yinoke Pharmaceutical Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Liganlong Granules market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Liganlong Granules and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Liganlong Granules sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Liganlong Granules market size, projected growth trends, production technologies, key applications, and end-use industries.

Liganlong Granules Segment by Company

Zhongjing Wanxi Pharmaceutical Co., Ltd.

Tibet Tibetan Medicine Group Co., Ltd.

Sichuan Luye Pharmaceutical Co., Ltd.

Liaoning Wohua Kangchen Pharmaceutical Co., Ltd.

Liaoning Keji Pharmaceutical Co., Ltd.

Liaoning Dongyi Pharmaceutical Co., Ltd.

Jiangxi Chuanqi Pharmaceutical Co., Ltd.

Jilin Yatai Pharmaceutical Co., Ltd.

Jilin Yinoke Pharmaceutical Co., Ltd.

Jilin Aodong Yanbian Pharmaceutical Co., Ltd.

Heilongjiang Tianhong Pharmaceutical Co., Ltd.

Heilongjiang Sinopharm Shuanglanxing Pharmaceutical Co., Ltd.

Hainan Zhongbao Pharmaceutical Co., Ltd.

Sinopharm Group Yibin Pharmaceutical Co., Ltd.

Guizhou Dalong Pharmaceutical Co., Ltd.

Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd.

Guangxi Xiuzhen Pharmaceutical Co., Ltd.

Guangxi Nanning Yongjiang Pharmaceutical Co., Ltd.

Guangxi Huibaoyuan Pharmaceutical Technology Co., Ltd.

Dalian Meiluo Chinese Medicine Factory Co., Ltd.

Dalian Hanfang Pharmaceutical Co., Ltd.

Liganlong Granules Segment by Type

5g

10g

Liganlong Granules Segment by Application

Hospital

Clinic

Other

Liganlong Granules Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Liganlong Granules status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Liganlong Granules market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Liganlong Granules significant trends, drivers, influence factors in global and regions.

6. To analyze Liganlong Granules competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Liganlong Granules market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Liganlong Granules and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Liganlong Granules.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Liganlong Granules market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Liganlong Granules industry.

Chapter 3: Detailed analysis of Liganlong Granules manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Liganlong Granules in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Liganlong Granules in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Liganlong Granules Industry Trends Table 2. Liganlong Granules Industry Drivers Table 3. Liganlong Granules Industry Opportunities and Challenges Table 4. Liganlong Granules Industry Restraints Table 5. Global Liganlong Granules Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Liganlong Granules Revenue Share by Company (2021-2026) Table 7. Global Liganlong Granules Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Liganlong Granules Sales Volume Share by Company (2021-2026) Table 9. Global Liganlong Granules Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Liganlong Granules Company Ranking, (2024-2026) & (USD Million) Table 11. Global Liganlong Granules Key Company Manufacturing Base & Headquarters Table 12. Global Liganlong Granules Company, Product Type & Application Table 13. Global Liganlong Granules Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Liganlong Granules by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 5g Table 18. Significant Companies of 10g Table 19. Global Liganlong Granules Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Liganlong Granules Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Liganlong Granules Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Liganlong Granules Sales Volume Share by Type (2021-2026) Table 23. Global Liganlong Granules Sales Volume Share by Type (2027-2032) Table 24. Global Liganlong Granules Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Liganlong Granules Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Liganlong Granules Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Liganlong Granules Sales Value Share by Type (2021-2026) Table 28. Global Liganlong Granules Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospital Table 30. Significant Companies of Clinic Table 31. Significant Companies of Other Table 32. Global Liganlong Granules Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Liganlong Granules Sales Volume by Application (2021-2026) & (K Units) Table 34. Global Liganlong Granules Sales Volume by Application (2027-2032) & (K Units) Table 35. Global Liganlong Granules Sales Volume Share by Application (2021-2026) Table 36. Global Liganlong Granules Sales Volume Share by Application (2027-2032) Table 37. Global Liganlong Granules Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Liganlong Granules Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Liganlong Granules Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Liganlong Granules Sales Value Share by Application (2021-2026) Table 41. Global Liganlong Granules Sales Value Share by Application (2027-2032) Table 42. Global Liganlong Granules Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Liganlong Granules Sales by Region (2021-2026) & (K Units) Table 44. Global Liganlong Granules Sales Market Share by Region (2021-2026) Table 45. Global Liganlong Granules Sales by Region (2027-2032) & (K Units) Table 46. Global Liganlong Granules Sales Market Share by Region (2027-2032) Table 47. Global Liganlong Granules Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Liganlong Granules Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Liganlong Granules Sales Value Share by Region (2021-2026) Table 50. Global Liganlong Granules Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Liganlong Granules Sales Value Share by Region (2027-2032) Table 52. Global Liganlong Granules Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global Liganlong Granules Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global Liganlong Granules Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Global Liganlong Granules Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Liganlong Granules Sales by Country (2021-2026) & (K Units) Table 57. Global Liganlong Granules Sales Market Share by Country (2021-2026) Table 58. Global Liganlong Granules Sales by Country (2027-2032) & (K Units) Table 59. Global Liganlong Granules Sales Market Share by Country (2027-2032) Table 60. Global Liganlong Granules Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Liganlong Granules Sales Value Market Share by Country (2021-2026) Table 62. Global Liganlong Granules Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Liganlong Granules Sales Value Market Share by Country (2027-2032) Table 64. Zhongjing Wanxi Pharmaceutical Co., Ltd. Company Information Table 65. Zhongjing Wanxi Pharmaceutical Co., Ltd. Business Overview Table 66. Zhongjing Wanxi Pharmaceutical Co., Ltd. Liganlong Granules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Zhongjing Wanxi Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio Table 68. Zhongjing Wanxi Pharmaceutical Co., Ltd. Recent Development Table 69. Tibet Tibetan Medicine Group Co., Ltd. Company Information Table 70. Tibet Tibetan Medicine Group Co., Ltd. Business Overview Table 71. Tibet Tibetan Medicine Group Co., Ltd. Liganlong Granules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Tibet Tibetan Medicine Group Co., Ltd. Liganlong Granules Product Portfolio Table 73. Tibet Tibetan Medicine Group Co., Ltd. Recent Development Table 74. Sichuan Luye Pharmaceutical Co., Ltd. Company Information Table 75. Sichuan Luye Pharmaceutical Co., Ltd. Business Overview Table 76. Sichuan Luye Pharmaceutical Co., Ltd. Liganlong Granules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Sichuan Luye Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio Table 78. Sichuan Luye Pharmaceutical Co., Ltd. Recent Development Table 79. Liaoning Wohua Kangchen Pharmaceutical Co., Ltd. Company Information Table 80. Liaoning Wohua Kangchen Pharmaceutical Co., Ltd. Business Overview Table 81. Liaoning Wohua Kangchen Pharmaceutical Co., Ltd. Liganlong Granules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Liaoning Wohua Kangchen Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio Table 83. Liaoning Wohua Kangchen Pharmaceutical Co., Ltd. Recent Development Table 84. Liaoning Keji Pharmaceutical Co., Ltd. Company Information Table 85. Liaoning Keji Pharmaceutical Co., Ltd. Business Overview Table 86. Liaoning Keji Pharmaceutical Co., Ltd. Liganlong Granules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Liaoning Keji Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio Table 88. Liaoning Keji Pharmaceutical Co., Ltd. Recent Development Table 89. Liaoning Dongyi Pharmaceutical Co., Ltd. Company Information Table 90. Liaoning Dongyi Pharmaceutical Co., Ltd. Business Overview Table 91. Liaoning Dongyi Pharmaceutical Co., Ltd. Liganlong Granules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Liaoning Dongyi Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio Table 93. Liaoning Dongyi Pharmaceutical Co., Ltd. Recent Development Table 94. Jiangxi Chuanqi Pharmaceutical Co., Ltd. Company Information Table 95. Jiangxi Chuanqi Pharmaceutical Co., Ltd. Business Overview Table 96. Jiangxi Chuanqi Pharmaceutical Co., Ltd. Liganlong Granules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Jiangxi Chuanqi Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio Table 98. Jiangxi Chuanqi Pharmaceutical Co., Ltd. Recent Development Table 99. Jilin Yatai Pharmaceutical Co., Ltd. Company Information Table 100. Jilin Yatai Pharmaceutical Co., Ltd. Business Overview Table 101. Jilin Yatai Pharmaceutical Co., Ltd. Liganlong Granules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Jilin Yatai Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio Table 103. Jilin Yatai Pharmaceutical Co., Ltd. Recent Development Table 104. Jilin Yinoke Pharmaceutical Co., Ltd. Company Information Table 105. Jilin Yinoke Pharmaceutical Co., Ltd. Business Overview Table 106. Jilin Yinoke Pharmaceutical Co., Ltd. Liganlong Granules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Jilin Yinoke Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio Table 108. Jilin Yinoke Pharmaceutical Co., Ltd. Recent Development Table 109. Jilin Aodong Yanbian Pharmaceutical Co., Ltd. Company Information Table 110. Jilin Aodong Yanbian Pharmaceutical Co., Ltd. Business Overview Table 111. Jilin Aodong Yanbian Pharmaceutical Co., Ltd. Liganlong Granules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Jilin Aodong Yanbian Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio Table 113. Jilin Aodong Yanbian Pharmaceutical Co., Ltd. Recent Development Table 114. Heilongjiang Tianhong Pharmaceutical Co., Ltd. Company Information Table 115. Heilongjiang Tianhong Pharmaceutical Co., Ltd. Business Overview Table 116. Heilongjiang Tianhong Pharmaceutical Co., Ltd. Liganlong Granules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. Heilongjiang Tianhong Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio Table 118. Heilongjiang Tianhong Pharmaceutical Co., Ltd. Recent Development Table 119. Heilongjiang Sinopharm Shuanglanxing Pharmaceutical Co., Ltd. Company Information Table 120. Heilongjiang Sinopharm Shuanglanxing Pharmaceutical Co., Ltd. Business Overview Table 121. Heilongjiang Sinopharm Shuanglanxing Pharmaceutical Co., Ltd. Liganlong Granules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. Heilongjiang Sinopharm Shuanglanxing Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio Table 123. Heilongjiang Sinopharm Shuanglanxing Pharmaceutical Co., Ltd. Recent Development Table 124. Hainan Zhongbao Pharmaceutical Co., Ltd. Company Information Table 125. Hainan Zhongbao Pharmaceutical Co., Ltd. Business Overview Table 126. Hainan Zhongbao Pharmaceutical Co., Ltd. Liganlong Granules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 127. Hainan Zhongbao Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio Table 128. Hainan Zhongbao Pharmaceutical Co., Ltd. Recent Development Table 129. Sinopharm Group Yibin Pharmaceutical Co., Ltd. Company Information Table 130. Sinopharm Group Yibin Pharmaceutical Co., Ltd. Business Overview Table 131. Sinopharm Group Yibin Pharmaceutical Co., Ltd. Liganlong Granules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 132. Sinopharm Group Yibin Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio Table 133. Sinopharm Group Yibin Pharmaceutical Co., Ltd. Recent Development Table 134. Guizhou Dalong Pharmaceutical Co., Ltd. Company Information Table 135. Guizhou Dalong Pharmaceutical Co., Ltd. Business Overview Table 136. Guizhou Dalong Pharmaceutical Co., Ltd. Liganlong Granules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 137. Guizhou Dalong Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio Table 138. Guizhou Dalong Pharmaceutical Co., Ltd. Recent Development Table 139. Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Company Information Table 140. Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Business Overview Table 141. Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Liganlong Granules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 142. Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio Table 143. Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Recent Development Table 144. Guangxi Xiuzhen Pharmaceutical Co., Ltd. Company Information Table 145. Guangxi Xiuzhen Pharmaceutical Co., Ltd. Business Overview Table 146. Guangxi Xiuzhen Pharmaceutical Co., Ltd. Liganlong Granules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 147. Guangxi Xiuzhen Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio Table 148. Guangxi Xiuzhen Pharmaceutical Co., Ltd. Recent Development Table 149. Guangxi Nanning Yongjiang Pharmaceutical Co., Ltd. Company Information Table 150. Guangxi Nanning Yongjiang Pharmaceutical Co., Ltd. Business Overview Table 151. Guangxi Nanning Yongjiang Pharmaceutical Co., Ltd. Liganlong Granules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 152. Guangxi Nanning Yongjiang Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio Table 153. Guangxi Nanning Yongjiang Pharmaceutical Co., Ltd. Recent Development Table 154. Guangxi Huibaoyuan Pharmaceutical Technology Co., Ltd. Company Information Table 155. Guangxi Huibaoyuan Pharmaceutical Technology Co., Ltd. Business Overview Table 156. Guangxi Huibaoyuan Pharmaceutical Technology Co., Ltd. Liganlong Granules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 157. Guangxi Huibaoyuan Pharmaceutical Technology Co., Ltd. Liganlong Granules Product Portfolio Table 158. Guangxi Huibaoyuan Pharmaceutical Technology Co., Ltd. Recent Development Table 159. Dalian Meiluo Chinese Medicine Factory Co., Ltd. Company Information Table 160. Dalian Meiluo Chinese Medicine Factory Co., Ltd. Business Overview Table 161. Dalian Meiluo Chinese Medicine Factory Co., Ltd. Liganlong Granules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 162. Dalian Meiluo Chinese Medicine Factory Co., Ltd. Liganlong Granules Product Portfolio Table 163. Dalian Meiluo Chinese Medicine Factory Co., Ltd. Recent Development Table 164. Dalian Hanfang Pharmaceutical Co., Ltd. Company Information Table 165. Dalian Hanfang Pharmaceutical Co., Ltd. Business Overview Table 166. Dalian Hanfang Pharmaceutical Co., Ltd. Liganlong Granules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 167. Dalian Hanfang Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio Table 168. Dalian Hanfang Pharmaceutical Co., Ltd. Recent Development Table 169. Key Raw Materials Table 170. Raw Materials Key Suppliers Table 171. Liganlong Granules Distributors List Table 172. Liganlong Granules Customers List Table 173. Research Programs/Design for This Report Table 174. Authors List of This Report Table 175. Secondary Sources Table 176. Primary Sources List of Figures Figure 1. Liganlong Granules Product Image Figure 2. Global Liganlong Granules Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Liganlong Granules Sales Value (2021-2032) & (US$ Million) Figure 4. Global Liganlong Granules Sales (2021-2032) & (K Units) Figure 5. Global Liganlong Granules Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Liganlong Granules Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 5g Image Figure 10. 10g Image Figure 11. Global Liganlong Granules Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Liganlong Granules Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Liganlong Granules Sales Volume Share by Type (2021-2032) Figure 14. Global Liganlong Granules Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Liganlong Granules Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Liganlong Granules Sales Value Share by Type (2021-2032) Figure 17. Hospital Image Figure 18. Clinic Image Figure 19. Other Image Figure 20. Global Liganlong Granules Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Liganlong Granules Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Liganlong Granules Sales Volume Share by Application (2021-2032) Figure 23. Global Liganlong Granules Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Liganlong Granules Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Liganlong Granules Sales Value Share by Application (2021-2032) Figure 26. Global Liganlong Granules Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 27. Global Liganlong Granules Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Liganlong Granules Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Liganlong Granules Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Liganlong Granules Sales Value (2021-2032) & (US$ Million) Figure 31. North America Liganlong Granules Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Liganlong Granules Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Liganlong Granules Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Liganlong Granules Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Liganlong Granules Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Liganlong Granules Sales Value (2021-2032) & (US$ Million) Figure 37. South America Liganlong Granules Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Liganlong Granules Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Liganlong Granules Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Liganlong Granules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Liganlong Granules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Liganlong Granules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Liganlong Granules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Liganlong Granules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Liganlong Granules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Liganlong Granules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Liganlong Granules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Liganlong Granules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Liganlong Granules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Liganlong Granules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Liganlong Granules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Liganlong Granules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Liganlong Granules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Liganlong Granules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Liganlong Granules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Liganlong Granules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Liganlong Granules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Liganlong Granules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Liganlong Granules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Liganlong Granules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Liganlong Granules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Liganlong Granules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Liganlong Granules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Liganlong Granules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Liganlong Granules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Liganlong Granules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Liganlong Granules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Liganlong Granules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Liganlong Granules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Liganlong Granules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Liganlong Granules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Liganlong Granules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Liganlong Granules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Liganlong Granules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Liganlong Granules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Liganlong Granules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Liganlong Granules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Liganlong Granules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Liganlong Granules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Liganlong Granules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Liganlong Granules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Liganlong Granules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Liganlong Granules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Liganlong Granules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Liganlong Granules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Liganlong Granules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Liganlong Granules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Liganlong Granules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Liganlong Granules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Liganlong Granules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Liganlong Granules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Liganlong Granules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Liganlong Granules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Liganlong Granules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Liganlong Granules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Liganlong Granules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Liganlong Granules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Liganlong Granules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Liganlong Granules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Liganlong Granules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Liganlong Granules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Liganlong Granules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Liganlong Granules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Liganlong Granules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Liganlong Granules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Liganlong Granules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Liganlong Granules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Liganlong Granules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Liganlong Granules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Liganlong Granules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Liganlong Granules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Liganlong Granules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Liganlong Granules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Liganlong Granules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Liganlong Granules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Liganlong Granules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Liganlong Granules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Liganlong Granules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Liganlong Granules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Liganlong Granules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Liganlong Granules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Liganlong Granules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Liganlong Granules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Liganlong Granules Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Liganlong Granules Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • 5g
  • 10g
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Zhongjing Wanxi Pharmaceutical Co., Ltd.
  • Tibet Tibetan Medicine Group Co., Ltd.
  • Sichuan Luye Pharmaceutical Co., Ltd.
  • Liaoning Wohua Kangchen Pharmaceutical Co., Ltd.
  • Liaoning Keji Pharmaceutical Co., Ltd.
  • Liaoning Dongyi Pharmaceutical Co., Ltd.
  • Jiangxi Chuanqi Pharmaceutical Co., Ltd.
  • Jilin Yatai Pharmaceutical Co., Ltd.
  • Jilin Yinoke Pharmaceutical Co., Ltd.
  • Jilin Aodong Yanbian Pharmaceutical Co., Ltd.
  • Heilongjiang Tianhong Pharmaceutical Co., Ltd.
  • Heilongjiang Sinopharm Shuanglanxing Pharmaceutical Co., Ltd.
  • Hainan Zhongbao Pharmaceutical Co., Ltd.
  • Sinopharm Group Yibin Pharmaceutical Co., Ltd.
  • Guizhou Dalong Pharmaceutical Co., Ltd.
  • Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd.
  • Guangxi Xiuzhen Pharmaceutical Co., Ltd.
  • Guangxi Nanning Yongjiang Pharmaceutical Co., Ltd.
  • Guangxi Huibaoyuan Pharmaceutical Technology Co., Ltd.
  • Dalian Meiluo Chinese Medicine Factory Co., Ltd.
  • Dalian Hanfang Pharmaceutical Co., Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Liganlong Granules Sales Value (2021-2032)
  4. 1.2.2 Global Liganlong Granules Sales Volume (2021-2032)
  5. 1.2.3 Global Liganlong Granules Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Liganlong Granules Market Dynamics
  1. 2.1 Liganlong Granules Industry Trends
  2. 2.2 Liganlong Granules Industry Drivers
  3. 2.3 Liganlong Granules Industry Opportunities and Challenges
  4. 2.4 Liganlong Granules Industry Restraints
3 Liganlong Granules Market by Company
  1. 3.1 Global Liganlong Granules Company Revenue Ranking in 2025
  2. 3.2 Global Liganlong Granules Revenue by Company (2021-2026)
  3. 3.3 Global Liganlong Granules Sales Volume by Company (2021-2026)
  4. 3.4 Global Liganlong Granules Average Price by Company (2021-2026)
  5. 3.5 Global Liganlong Granules Company Ranking (2024-2026)
  6. 3.6 Global Liganlong Granules Company Manufacturing Base and Headquarters
  7. 3.7 Global Liganlong Granules Company Product Type and Application
  8. 3.8 Global Liganlong Granules Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Liganlong Granules Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Liganlong Granules Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Liganlong Granules Market by Type
  1. 4.1 Liganlong Granules Type Introduction
  2. 4.1.1 5g
  3. 4.1.2 10g
  4. 4.2 Global Liganlong Granules Sales Volume by Type
  5. 4.2.1 Global Liganlong Granules Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Liganlong Granules Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Liganlong Granules Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Liganlong Granules Sales Value by Type
  9. 4.3.1 Global Liganlong Granules Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Liganlong Granules Sales Value by Type (2021-2032)
  11. 4.3.3 Global Liganlong Granules Sales Value Share by Type (2021-2032)
5 Liganlong Granules Market by Application
  1. 5.1 Liganlong Granules Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Other
  5. 5.2 Global Liganlong Granules Sales Volume by Application
  6. 5.2.1 Global Liganlong Granules Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Liganlong Granules Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Liganlong Granules Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Liganlong Granules Sales Value by Application
  10. 5.3.1 Global Liganlong Granules Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Liganlong Granules Sales Value by Application (2021-2032)
  12. 5.3.3 Global Liganlong Granules Sales Value Share by Application (2021-2032)
6 Liganlong Granules Regional Sales and Value Analysis
  1. 6.1 Global Liganlong Granules Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Liganlong Granules Sales by Region (2021-2032)
  3. 6.2.1 Global Liganlong Granules Sales by Region: 2021-2026
  4. 6.2.2 Global Liganlong Granules Sales by Region (2027-2032)
  5. 6.3 Global Liganlong Granules Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Liganlong Granules Sales Value by Region (2021-2032)
  7. 6.4.1 Global Liganlong Granules Sales Value by Region: 2021-2026
  8. 6.4.2 Global Liganlong Granules Sales Value by Region (2027-2032)
  9. 6.5 Global Liganlong Granules Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Liganlong Granules Sales Value (2021-2032)
  12. 6.6.2 North America Liganlong Granules Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Liganlong Granules Sales Value (2021-2032)
  15. 6.7.2 Europe Liganlong Granules Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Liganlong Granules Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Liganlong Granules Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Liganlong Granules Sales Value (2021-2032)
  21. 6.9.2 South America Liganlong Granules Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Liganlong Granules Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Liganlong Granules Sales Value Share by Country, 2025 VS 2032
7 Liganlong Granules Country-level Sales and Value Analysis
  1. 7.1 Global Liganlong Granules Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Liganlong Granules Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Liganlong Granules Sales by Country (2021-2032)
  4. 7.3.1 Global Liganlong Granules Sales by Country (2021-2026)
  5. 7.3.2 Global Liganlong Granules Sales by Country (2027-2032)
  6. 7.4 Global Liganlong Granules Sales Value by Country (2021-2032)
  7. 7.4.1 Global Liganlong Granules Sales Value by Country (2021-2026)
  8. 7.4.2 Global Liganlong Granules Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Liganlong Granules Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Liganlong Granules Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Liganlong Granules Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Liganlong Granules Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Liganlong Granules Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Liganlong Granules Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Liganlong Granules Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Liganlong Granules Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Liganlong Granules Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Liganlong Granules Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Liganlong Granules Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Liganlong Granules Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Liganlong Granules Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Liganlong Granules Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Liganlong Granules Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Liganlong Granules Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Liganlong Granules Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Liganlong Granules Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Liganlong Granules Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Liganlong Granules Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Liganlong Granules Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Liganlong Granules Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Liganlong Granules Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Liganlong Granules Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Liganlong Granules Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Liganlong Granules Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Liganlong Granules Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Liganlong Granules Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Liganlong Granules Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Liganlong Granules Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Liganlong Granules Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Liganlong Granules Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Liganlong Granules Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Liganlong Granules Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Liganlong Granules Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Liganlong Granules Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Liganlong Granules Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Liganlong Granules Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Liganlong Granules Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Liganlong Granules Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Liganlong Granules Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Liganlong Granules Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Liganlong Granules Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Liganlong Granules Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Liganlong Granules Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Liganlong Granules Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Liganlong Granules Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Liganlong Granules Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Liganlong Granules Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Liganlong Granules Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Liganlong Granules Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Liganlong Granules Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Liganlong Granules Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Liganlong Granules Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Liganlong Granules Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Liganlong Granules Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Liganlong Granules Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Liganlong Granules Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Liganlong Granules Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Liganlong Granules Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Liganlong Granules Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Liganlong Granules Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Liganlong Granules Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Liganlong Granules Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Liganlong Granules Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Liganlong Granules Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Liganlong Granules Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Liganlong Granules Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Liganlong Granules Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Liganlong Granules Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Liganlong Granules Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Liganlong Granules Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Liganlong Granules Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Liganlong Granules Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Liganlong Granules Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Liganlong Granules Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Liganlong Granules Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Liganlong Granules Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Liganlong Granules Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Liganlong Granules Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Liganlong Granules Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Liganlong Granules Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Liganlong Granules Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Liganlong Granules Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Zhongjing Wanxi Pharmaceutical Co., Ltd.
  2. 8.1.1 Zhongjing Wanxi Pharmaceutical Co., Ltd. Company Information
  3. 8.1.2 Zhongjing Wanxi Pharmaceutical Co., Ltd. Business Overview
  4. 8.1.3 Zhongjing Wanxi Pharmaceutical Co., Ltd. Liganlong Granules Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Zhongjing Wanxi Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio
  6. 8.1.5 Zhongjing Wanxi Pharmaceutical Co., Ltd. Recent Developments
  7. 8.2 Tibet Tibetan Medicine Group Co., Ltd.
  8. 8.2.1 Tibet Tibetan Medicine Group Co., Ltd. Company Information
  9. 8.2.2 Tibet Tibetan Medicine Group Co., Ltd. Business Overview
  10. 8.2.3 Tibet Tibetan Medicine Group Co., Ltd. Liganlong Granules Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Tibet Tibetan Medicine Group Co., Ltd. Liganlong Granules Product Portfolio
  12. 8.2.5 Tibet Tibetan Medicine Group Co., Ltd. Recent Developments
  13. 8.3 Sichuan Luye Pharmaceutical Co., Ltd.
  14. 8.3.1 Sichuan Luye Pharmaceutical Co., Ltd. Company Information
  15. 8.3.2 Sichuan Luye Pharmaceutical Co., Ltd. Business Overview
  16. 8.3.3 Sichuan Luye Pharmaceutical Co., Ltd. Liganlong Granules Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Sichuan Luye Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio
  18. 8.3.5 Sichuan Luye Pharmaceutical Co., Ltd. Recent Developments
  19. 8.4 Liaoning Wohua Kangchen Pharmaceutical Co., Ltd.
  20. 8.4.1 Liaoning Wohua Kangchen Pharmaceutical Co., Ltd. Company Information
  21. 8.4.2 Liaoning Wohua Kangchen Pharmaceutical Co., Ltd. Business Overview
  22. 8.4.3 Liaoning Wohua Kangchen Pharmaceutical Co., Ltd. Liganlong Granules Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Liaoning Wohua Kangchen Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio
  24. 8.4.5 Liaoning Wohua Kangchen Pharmaceutical Co., Ltd. Recent Developments
  25. 8.5 Liaoning Keji Pharmaceutical Co., Ltd.
  26. 8.5.1 Liaoning Keji Pharmaceutical Co., Ltd. Company Information
  27. 8.5.2 Liaoning Keji Pharmaceutical Co., Ltd. Business Overview
  28. 8.5.3 Liaoning Keji Pharmaceutical Co., Ltd. Liganlong Granules Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Liaoning Keji Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio
  30. 8.5.5 Liaoning Keji Pharmaceutical Co., Ltd. Recent Developments
  31. 8.6 Liaoning Dongyi Pharmaceutical Co., Ltd.
  32. 8.6.1 Liaoning Dongyi Pharmaceutical Co., Ltd. Company Information
  33. 8.6.2 Liaoning Dongyi Pharmaceutical Co., Ltd. Business Overview
  34. 8.6.3 Liaoning Dongyi Pharmaceutical Co., Ltd. Liganlong Granules Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Liaoning Dongyi Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio
  36. 8.6.5 Liaoning Dongyi Pharmaceutical Co., Ltd. Recent Developments
  37. 8.7 Jiangxi Chuanqi Pharmaceutical Co., Ltd.
  38. 8.7.1 Jiangxi Chuanqi Pharmaceutical Co., Ltd. Company Information
  39. 8.7.2 Jiangxi Chuanqi Pharmaceutical Co., Ltd. Business Overview
  40. 8.7.3 Jiangxi Chuanqi Pharmaceutical Co., Ltd. Liganlong Granules Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Jiangxi Chuanqi Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio
  42. 8.7.5 Jiangxi Chuanqi Pharmaceutical Co., Ltd. Recent Developments
  43. 8.8 Jilin Yatai Pharmaceutical Co., Ltd.
  44. 8.8.1 Jilin Yatai Pharmaceutical Co., Ltd. Company Information
  45. 8.8.2 Jilin Yatai Pharmaceutical Co., Ltd. Business Overview
  46. 8.8.3 Jilin Yatai Pharmaceutical Co., Ltd. Liganlong Granules Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Jilin Yatai Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio
  48. 8.8.5 Jilin Yatai Pharmaceutical Co., Ltd. Recent Developments
  49. 8.9 Jilin Yinoke Pharmaceutical Co., Ltd.
  50. 8.9.1 Jilin Yinoke Pharmaceutical Co., Ltd. Company Information
  51. 8.9.2 Jilin Yinoke Pharmaceutical Co., Ltd. Business Overview
  52. 8.9.3 Jilin Yinoke Pharmaceutical Co., Ltd. Liganlong Granules Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Jilin Yinoke Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio
  54. 8.9.5 Jilin Yinoke Pharmaceutical Co., Ltd. Recent Developments
  55. 8.10 Jilin Aodong Yanbian Pharmaceutical Co., Ltd.
  56. 8.10.1 Jilin Aodong Yanbian Pharmaceutical Co., Ltd. Company Information
  57. 8.10.2 Jilin Aodong Yanbian Pharmaceutical Co., Ltd. Business Overview
  58. 8.10.3 Jilin Aodong Yanbian Pharmaceutical Co., Ltd. Liganlong Granules Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Jilin Aodong Yanbian Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio
  60. 8.10.5 Jilin Aodong Yanbian Pharmaceutical Co., Ltd. Recent Developments
  61. 8.11 Heilongjiang Tianhong Pharmaceutical Co., Ltd.
  62. 8.11.1 Heilongjiang Tianhong Pharmaceutical Co., Ltd. Company Information
  63. 8.11.2 Heilongjiang Tianhong Pharmaceutical Co., Ltd. Business Overview
  64. 8.11.3 Heilongjiang Tianhong Pharmaceutical Co., Ltd. Liganlong Granules Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Heilongjiang Tianhong Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio
  66. 8.11.5 Heilongjiang Tianhong Pharmaceutical Co., Ltd. Recent Developments
  67. 8.12 Heilongjiang Sinopharm Shuanglanxing Pharmaceutical Co., Ltd.
  68. 8.12.1 Heilongjiang Sinopharm Shuanglanxing Pharmaceutical Co., Ltd. Company Information
  69. 8.12.2 Heilongjiang Sinopharm Shuanglanxing Pharmaceutical Co., Ltd. Business Overview
  70. 8.12.3 Heilongjiang Sinopharm Shuanglanxing Pharmaceutical Co., Ltd. Liganlong Granules Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Heilongjiang Sinopharm Shuanglanxing Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio
  72. 8.12.5 Heilongjiang Sinopharm Shuanglanxing Pharmaceutical Co., Ltd. Recent Developments
  73. 8.13 Hainan Zhongbao Pharmaceutical Co., Ltd.
  74. 8.13.1 Hainan Zhongbao Pharmaceutical Co., Ltd. Company Information
  75. 8.13.2 Hainan Zhongbao Pharmaceutical Co., Ltd. Business Overview
  76. 8.13.3 Hainan Zhongbao Pharmaceutical Co., Ltd. Liganlong Granules Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Hainan Zhongbao Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio
  78. 8.13.5 Hainan Zhongbao Pharmaceutical Co., Ltd. Recent Developments
  79. 8.14 Sinopharm Group Yibin Pharmaceutical Co., Ltd.
  80. 8.14.1 Sinopharm Group Yibin Pharmaceutical Co., Ltd. Company Information
  81. 8.14.2 Sinopharm Group Yibin Pharmaceutical Co., Ltd. Business Overview
  82. 8.14.3 Sinopharm Group Yibin Pharmaceutical Co., Ltd. Liganlong Granules Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Sinopharm Group Yibin Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio
  84. 8.14.5 Sinopharm Group Yibin Pharmaceutical Co., Ltd. Recent Developments
  85. 8.15 Guizhou Dalong Pharmaceutical Co., Ltd.
  86. 8.15.1 Guizhou Dalong Pharmaceutical Co., Ltd. Company Information
  87. 8.15.2 Guizhou Dalong Pharmaceutical Co., Ltd. Business Overview
  88. 8.15.3 Guizhou Dalong Pharmaceutical Co., Ltd. Liganlong Granules Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Guizhou Dalong Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio
  90. 8.15.5 Guizhou Dalong Pharmaceutical Co., Ltd. Recent Developments
  91. 8.16 Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd.
  92. 8.16.1 Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Company Information
  93. 8.16.2 Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Business Overview
  94. 8.16.3 Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Liganlong Granules Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio
  96. 8.16.5 Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Recent Developments
  97. 8.17 Guangxi Xiuzhen Pharmaceutical Co., Ltd.
  98. 8.17.1 Guangxi Xiuzhen Pharmaceutical Co., Ltd. Company Information
  99. 8.17.2 Guangxi Xiuzhen Pharmaceutical Co., Ltd. Business Overview
  100. 8.17.3 Guangxi Xiuzhen Pharmaceutical Co., Ltd. Liganlong Granules Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Guangxi Xiuzhen Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio
  102. 8.17.5 Guangxi Xiuzhen Pharmaceutical Co., Ltd. Recent Developments
  103. 8.18 Guangxi Nanning Yongjiang Pharmaceutical Co., Ltd.
  104. 8.18.1 Guangxi Nanning Yongjiang Pharmaceutical Co., Ltd. Company Information
  105. 8.18.2 Guangxi Nanning Yongjiang Pharmaceutical Co., Ltd. Business Overview
  106. 8.18.3 Guangxi Nanning Yongjiang Pharmaceutical Co., Ltd. Liganlong Granules Sales, Value and Gross Margin (2021-2026)
  107. 8.18.4 Guangxi Nanning Yongjiang Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio
  108. 8.18.5 Guangxi Nanning Yongjiang Pharmaceutical Co., Ltd. Recent Developments
  109. 8.19 Guangxi Huibaoyuan Pharmaceutical Technology Co., Ltd.
  110. 8.19.1 Guangxi Huibaoyuan Pharmaceutical Technology Co., Ltd. Company Information
  111. 8.19.2 Guangxi Huibaoyuan Pharmaceutical Technology Co., Ltd. Business Overview
  112. 8.19.3 Guangxi Huibaoyuan Pharmaceutical Technology Co., Ltd. Liganlong Granules Sales, Value and Gross Margin (2021-2026)
  113. 8.19.4 Guangxi Huibaoyuan Pharmaceutical Technology Co., Ltd. Liganlong Granules Product Portfolio
  114. 8.19.5 Guangxi Huibaoyuan Pharmaceutical Technology Co., Ltd. Recent Developments
  115. 8.20 Dalian Meiluo Chinese Medicine Factory Co., Ltd.
  116. 8.20.1 Dalian Meiluo Chinese Medicine Factory Co., Ltd. Company Information
  117. 8.20.2 Dalian Meiluo Chinese Medicine Factory Co., Ltd. Business Overview
  118. 8.20.3 Dalian Meiluo Chinese Medicine Factory Co., Ltd. Liganlong Granules Sales, Value and Gross Margin (2021-2026)
  119. 8.20.4 Dalian Meiluo Chinese Medicine Factory Co., Ltd. Liganlong Granules Product Portfolio
  120. 8.20.5 Dalian Meiluo Chinese Medicine Factory Co., Ltd. Recent Developments
  121. 8.21 Dalian Hanfang Pharmaceutical Co., Ltd.
  122. 8.21.1 Dalian Hanfang Pharmaceutical Co., Ltd. Company Information
  123. 8.21.2 Dalian Hanfang Pharmaceutical Co., Ltd. Business Overview
  124. 8.21.3 Dalian Hanfang Pharmaceutical Co., Ltd. Liganlong Granules Sales, Value and Gross Margin (2021-2026)
  125. 8.21.4 Dalian Hanfang Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio
  126. 8.21.5 Dalian Hanfang Pharmaceutical Co., Ltd. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Liganlong Granules Value Chain Analysis
  2. 9.1.1 Liganlong Granules Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Liganlong Granules Sales Mode & Process
  6. 9.2 Liganlong Granules Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Liganlong Granules Distributors
  9. 9.2.3 Liganlong Granules Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst